Second‐line treatments and outcomes for immune thrombocytopenia: A retrospective study with electronic health records

by Lincy S. Lal, Qayyim Said, Katherine Andrade, Adam Cuker
Published 2020-10-01

Evaluation of Patient Assistance Program Eligibility and Availability for Top 200 Brand Name and Generic Drugs in the United States

by Chin-Fun Chu, Lincy S Lal, Tisha M Felder, Pauline Rosenau
Published 2012-01-01

Evaluation of Patient Assistance Program Eligibility and Availability for Top 200 Brand Name and Generic Drugs in the United States

by Chin-Fun Chu, Lincy S Lal, Tisha M Felder, Pauline Rosenau
Published 2012-01-01

Treatment patterns and outcomes in pancreatic cancer: Retrospective claims analysis

by Yunes Doleh, Lincy S. Lal, Cori Blauer‐Petersen, Giovanni Antico, Michael Pishvaian
Published 2020-05-01

Evaluation of Rational Use of Medications in the United States

by Lincy Subha Lal PharmD, PhD, Pauline Vaillancourt Rosenau PhD
Published 2010-04-01

The evaluation of comprehensive medication management for chronic diseases in primary care clinics, a Texas delivery system reform incentive payment program

by Tong Han Chung, Ricardo J. Hernandez, Anaelle Libaud-Moal, Linh K. Nguyen, Lincy S. Lal, J. Michael Swint, Pio Juan Lansangan, Yen-Chi L. Le
Published 2020-07-01

Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial

by K. Ranh Voong, MD MPH, Lincy S. Lal, PhD, Deborah A. Kuban, MD, Thomas J. Pugh, MD, J. Michael Swint, PhD, Joy Godby, Seungtaek Choi, MD, Andrew K. Lee, MD MPH, Pamela J. Schlembach, MD, Steven J. Frank, MD, Sean E. McGuire, MD PhD, Karen E. Hoffman, MD MPH
Published 2017-07-01